Practice Management: Page 764

Nucletron appoints new executives

Radiotherapy provider Nucletron of Veenendaal, Netherlands, newly separated from former parent Delft Instruments, has made two new executive appointments, the company reported.

December 19, 2007

Making dollars and sense out of Medicaid and FFDM reimbursement

By Marty Graham

With the emergence of digital mammography, the U.S. Centers for Medicare and Medicaid Services (CMS) created a new billing code to differentiate digital from the longstanding code for analog. However, the existence of the new code doesn't mean it's being used or even acknowledged on the state level. Some Medicaid programs recognize it and reimburse accordingly, while other states don't pay for it at all. To help clear up the situation, AuntMinnie.com took on the task of compiling FFDM policies and reimbursement rates for all 50 states.

December 19, 2007

Diagnostic Health moves to new location

By AuntMinnie.com staff writers

Imaging services provider Diagnostic Health (DHC) has moved to a new location in its home town of Birmingham, AL.

December 17, 2007

Healthcare IT makes for better patient outcomes, study finds

By AuntMinnie.com staff writers

Patients have better health outcomes if they receive treatment at hospitals using healthcare information technology (IT) systems, according to a Florida State University (FSU) study.

December 13, 2007

Web-based order entry improves CT, MRI exam use patterns

By Kate Madden Yee

A Web-based radiology order entry (ROE) system can help make ordering high-cost imaging exams more "sensitive and specific," according to researchers from Boston. They found that the decision-support tool could help facilities better understand whether high-cost modalities such as CT and MRI are over- or underused based on radiology exam ordering patterns.

December 13, 2007

IsoRay's cesium isotope used for eye cancer

By AuntMinnie.com staff writers

Medical isotope developer IsoRay's cesium-131 seeds have been used for an application besides prostate cancer, the product's main clinical application, the Richland, WA-based company reported.

December 12, 2007